Intimation of the outcome of the Board meeting dated May 13 2026 for approval of the Standalone and Consolidated Financial Results for the quarter and year ended March 31 2026
13-May-2026
Download PDF
Onesource Specialty Pharma
Intimation of the outcome of the Board meeting dated May 13 2026 for approval of the Standalone and Consolidated Financial Results for the quarter and year ended March 31 2026
Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds